A study from Mayo Clinic – reported at the MAOA annual meeting – found no differences in pain and early functional outcomes in direct anterior THA patients vs. mini-posterior THA patients regardless of any changes in serum biomarkers for muscle damage.
What do increased serum biomarkers of inflammation/muscle damage tell us about pain and early functional outcomes following total hip arthroplasty (THA)?
According to a study from Mayo Clinic, not as much as orthopaedic surgeons may have been led to believe.
The study, presented at the Mid-America Orthopaedic Association’s annual meeting, sought to “determine the correlation, if any, between serum markers of muscle damage and early functional outcomes in patients undergoing total hip arthroplasty with either a direct anterior or mini-posterior approach,” said Michael J. Taunton, MD, one of the study co-authors.
Source: Healio